Naloxone does not antagonize the antihypertensive effect of chronic captopril therapy in hypertensive patients

Cardiovascular Drugs and Therapy
G P BerniniA Salvetti

Abstract

It has been reported that naloxone, an opiate receptor antagonist, blunts the hypotensive effect of captopril in normotensives. However, our previous data did not show any interaction between captopril given acutely and naloxone (0.1 mg/kg) in hypertensives. To test whether a greater naloxone dose could interfere with the hemodynamic effect of chronically administered captopril, 12 male hypertensives were studied: Six of them had been under captopril treatment (50 mg tid) for at least 1 month, whereas the others had been drug free for the same time. Both groups randomly received a saline or naloxone (0.2 mg/kg) infusion for 1 hour, and blood pressure, heart rate, PRA, plasma aldosterone, adrenaline, and noradrenaline were measured at regular intervals before, during, and after naloxone infusion. In drug-free hypertensives, naloxone tended to reduce blood pressure slightly and did not modify heart rate, PRA, plasma aldosterone, adrenaline, or noradrenaline. In captopril-treated hypertensives, naloxone did not blunt the hypotensive effect of captopril, but rather enhanced it, without changing the heart rate, adrenaline, and noradrenaline. Moreover, naloxone increased the renin-stimulating action and did not modify the aldosterone...Continue Reading

References

Jun 16, 1979·Lancet·P RubinT Blaschke
Oct 26, 1979·European Journal of Pharmacology·A ArreguiL L Iversen
Nov 5, 1979·Life Sciences·J SawynokF S LaBella
Nov 1, 1985·Clinical Pharmacology and Therapeutics·A A AjayiJ L Reid
May 1, 1986·British Journal of Clinical Pharmacology·A A AjayiJ L Reid
Jan 1, 1983·British Medical Bulletin·D S McQueen
Jun 1, 1984·Clinical Science·P C Rubin
Jun 1, 1984·British Journal of Clinical Pharmacology·P C RubinJ L Reid
May 1, 1983·Clinical and Experimental Pharmacology & Physiology·J A MillarJ L Reid
Nov 1, 1983·British Journal of Pharmacology·R Di NicolantonioM Veroni
Jan 1, 1984·Clinical and Experimental Hypertension. Part A, Theory and Practice·J L MontastrucP Montastruc
Dec 1, 1982·British Journal of Clinical Pharmacology·A SturaniP Zucchelli
Jul 1, 1983·Hypertension·P C RubinJ L Reid
Jan 28, 1982·The New England Journal of Medicine·D G VidtF M Fouad

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.